Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
EN | CN

You are here:Home-Chemical Inhibitors & Agonists-JAK/STAT Signaling-JAK-Ruxolitinib S enantiomer
Ruxolitinib S enantiomer

Chemical Structure : Ruxolitinib S enantiomer

CAS No.: 941685-37-6

Ruxolitinib S enantiomer (S-Ruxolitinib;INCB-018424 S enantiomer)

Catalog No.: PC-45873Not For Human Use, Lab Use Only.

The chirality of Ruxolitinib (INCB-018424), which is a potent, selective, orally active JAK1/JAK2 inhibitor with IC50 of 3.3/2.8 nM, respectively..

Packing Price Stock Quantity
5 mg $168 In stock
25 mg $445 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

The chirality of Ruxolitinib (INCB-018424), which is a potent, selective, orally active JAK1/JAK2 inhibitor with IC50 of 3.3/2.8 nM, respectively.

Physicochemical Properties

M.Wt 306.365
Formula C17H18N6
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βS)-

References

1. Quintás-Cardama A, et al. Blood. 2010 Apr 15;115(15):3109-17.

2. Fridman JS, et al. J Immunol. 2010 May 1;184(9):5298-307.

3. Verstovsek S, et al. N Engl J Med. 2010 Sep 16;363(12):1117-27.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: